DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02096 SIMCERE PHARMA

Trading Add to Porfolio
Index Constituent : HS Composite Index, HS Comp. L & M Index, HS Comp. MidCap Ind, HS Comp. M & S Index, Stock Connect HK Ind, Stock Connect HK MS
Major Shareholders REN Jinsheng & Associates (72.26%) Sector Health Care & Biotechnology
Web Site http://www.simcere.com Tel (86 25) 8556-6666
Email simcere@simcere.com Fax (86 25) 8526-2330
Related Equities N/A
Principal Activities Principally engaged in the research and development, manufacturing and sales of pharmaceutical products as well as rendering promotion service of pharmaceutical products that are not manufactured by the Group.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top